Aurora Cannabis has expanded its compassionate pricing program for medical marijuana patients in Canada, increasing the income eligibility threshold from $40,000 to $60,000 CAD annually.
The change is intended to make medical marijuana more accessible to a broader range of patients.
“As over half of the country’s adult population fits within this income threshold, our compassionate pricing program represents the most accessible, inclusive pricing plan to access medical cannabis in Canada,” said Geoff Hoover, senior vice president of Canadian commercial operations at Aurora. “We’re committed to breaking down barriers to access high quality medical cannabis, and this change empowers more patients to explore different treatment options at pricing they can afford.”
The expanded pricing program is available through AuroraMedical.com and coincides with the release of new products, including:
-
Aurora | Mediora Minis – Cannatonic CBD Flower, Sativa (10mg)
-
Daily Special | Sativa J’s – THC Pre-Rolls, Sativa (7 x 0.3g)
-
WMMC | Seasonal Stash Petro Biscuit – THC Flower, Indica (10mg)
In addition to income-based assistance, Aurora provides support and resources for seniors, veterans, pediatric patients, first responders, and others who use marijuana for medical purposes.
Aurora’s medical cannabis brands include Aurora, MedReleaf, CanniMed, and Whistler Medical Marijuana Co., with operations across Canada and international markets like Europe and Australia.
